CELLECT BIOTECHNOLOGY news, videos and press releases
For more news please use our advanced search feature.
CELLECT BIOTECHNOLOGY - More news...
CELLECT BIOTECHNOLOGY - More news...
-
“The Buzz'' Show: Cellect Biotechnology Ltd. (NASDAQ: APOP) ApoGraft Transplantation in U.S. Patient
- Thinking about buying stock in Meta Materials, Cellect Biotechnology, Forte Biosciences, Camber Energy, or Denison Mines?
- Thinking about buying stock in Citius Pharmaceuticals, New Oriental Education, Cellect Biotechnology, Novan, or Seanergy Maritime?
-
Cellect Biotechnology Ltd. - APOP Stock Chart Technical Analysis for 03-25-2021
- Thinking about buying stock in Cellect Biotechnology, Castor Maritime, AMC Entertainment, Immutep, or Hall of Fame Resort & Entertainment?
-
Cellect Biotechnology Ltd. - APOP Stock Chart Technical Analysis for 10-29-2020
- Cellect Biotechnology Reports Second Quarter Financial and Operating Results; First Half 2020 Strategic Developments Create Long-Term Revenue Catalysts
- European Patent Office Grants Cellect Biotechnology Pivotal Patent for Stem Cells Activation
- Cellect Biotechnology Reports First Quarter 2020 Financial and Operating Results; Continues to Demonstrate Significant Progress Despite Adjusted Operations Due to COVID-19
- Cellect Biotechnology's ApoGraft™ to Empower Cellular Treatment of COVID-19 Related Pulmonary Diseases
-
Cellect Biotechnology Ltd. - APOP Stock Chart Technical Analysis for 05-11-2020
- Cellect Biotechnology Announces Positive Data Demonstrating Robust Engraftment Using ApoGraft was Featured in Bone Marrow Transplantation; Primary Data Points Were Submitted to the FDA During Investigational New Drug Approval Process
- Cellect Biotechnology Continues to Achieve Milestones; Receives New Patent Allowance in Canada
- Cellect Biotechnology Reports Fourth Quarter and Full Year 2019 Results
- Cellect Biotechnology Receives New Patent Allowance in China
- Cellect Biotechnology and Canndoc Ltd. to Enter Into Strategic Pharma Grade Cannabis Commercial Deal for Reduction in Opioid Usage
- Cellect Biotechnology Ltd. Prices $3m Registered Direct Offering of American Depositary Shares
-
Cellect Biotechnology Ltd. - APOP Stock Chart Technical Analysis for 01-07-2020
- Cellect Biotechnology Strengthens IP Portfolio; Receives "Intention to Grant" Patents from European and Israeli Patent Offices
- Cellect Biotechnology Receives Approval for U.S. Clinical Trial
- Cellect Biotechnology Reports Third Quarter 2019 Financial and Operating Results
- Cellect Biotechnology Regains Compliance With Nasdaq Minimum Bid Price Requirement
-
Cellect Biotechnology Ltd. - APOP Stock Chart Technical Analysis for 10-24-2019
-
Cellect Biotechnology Ltd. - APOP Stock Chart Technical Analysis for 10-23-2019
- Cellect Biotechnology Reports Second Quarter 2019 Financial and Operating Results
-
Cellect Biotechnology Ltd. - APOP Stock Chart Technical Analysis for 08-12-2019
- Cellect Biotechnology Announces Positive Outcome From Safety Review Committee; Successfully Transplants 9th Clinical Trial Patient
- Cellect Biotechnology and Washington University (WU) Finalize Accelerated Clinical Trial Agreement
- Cellect Biotechnology Reports First Quarter 2019 Financial and Operating Results
- Cellect Announces Positive Phase I/II Mid-Study Results of Its ApoGraft™ Technology
